These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 30234130)
21. ACE-inhibitor, AT1-receptor-antagonist, or both? A clinical pharmacologist's perspective after publication of the results of ONTARGET. Schindler C Ther Adv Cardiovasc Dis; 2008 Aug; 2(4):233-48. PubMed ID: 19124424 [TBL] [Abstract][Full Text] [Related]
22. Retrospective analysis of real-world efficacy of angiotensin receptor blockers versus other classes of antihypertensive agents in blood pressure management. Petrella R; Michailidis P Clin Ther; 2011 Sep; 33(9):1190-203. PubMed ID: 21885126 [TBL] [Abstract][Full Text] [Related]
23. Methylene blue is associated with poor outcomes in vasoplegic shock. Weiner MM; Lin HM; Danforth D; Rao S; Hosseinian L; Fischer GW J Cardiothorac Vasc Anesth; 2013 Dec; 27(6):1233-8. PubMed ID: 23972738 [TBL] [Abstract][Full Text] [Related]
24. Methylene Blue for Vasoplegic Syndrome. Booth AT; Melmer PD; Tribble B; Mehaffey JH; Tribble C Heart Surg Forum; 2017 Oct; 20(5):E234-E238. PubMed ID: 29087290 [TBL] [Abstract][Full Text] [Related]
25. The curious tale of perioperative precision medicine: a story of hydroxocobalamin and cardiac surgery-associated vasoplegia. Kertai MD; Shaw AD Can J Anaesth; 2018 May; 65(5):507-511. PubMed ID: 29423881 [No Abstract] [Full Text] [Related]
26. Comparison of direct renin inhibitor and angiotensin II receptor blocker on clinic and ambulatory blood pressure profiles in hypertension with chronic kidney disease. Uneda K; Tamura K; Wakui H; Azushima K; Haku S; Kobayashi R; Ohki K; Haruhara K; Kinguchi S; Ohsawa M; Fujikawa T; Umemura S Clin Exp Hypertens; 2016; 38(8):738-743. PubMed ID: 27936941 [TBL] [Abstract][Full Text] [Related]
27. Angiotensin II receptor blocker prevents increased arterial stiffness in patients with essential hypertension. Agata J; Nagahara D; Kinoshita S; Takagawa Y; Moniwa N; Yoshida D; Ura N; Shimamoto K Circ J; 2004 Dec; 68(12):1194-8. PubMed ID: 15564706 [TBL] [Abstract][Full Text] [Related]
28. Risk factors for vasoplegia after cardiac surgery: a meta-analysis. Dayan V; Cal R; Giangrossi F Interact Cardiovasc Thorac Surg; 2019 Jun; 28(6):838-844. PubMed ID: 30649312 [TBL] [Abstract][Full Text] [Related]
29. A novel design of combining the angiotensin converting enzyme (ACE) inhibitor captopril with the angiotensin receptor blocker (ARB) losartan using homo coupling via PEG diacid linker. Hashemzadeh M; Park S; Ju H; Movahed MR Recent Pat Cardiovasc Drug Discov; 2013 Dec; 8(3):221-5. PubMed ID: 24552291 [TBL] [Abstract][Full Text] [Related]
30. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better? Weir MR Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185 [TBL] [Abstract][Full Text] [Related]
31. Hydroxocobalamin for the treatment of cardiac surgery-associated vasoplegia: a case series. Shah PR; Reynolds PS; Pal N; Tang D; McCarthy H; Spiess BD Can J Anaesth; 2018 May; 65(5):560-568. PubMed ID: 29209927 [TBL] [Abstract][Full Text] [Related]
32. Renin-angiotensin-aldosterone-system inhibition is safe in the preoperative period surrounding carotid endarterectomy. Steely AM; Callas PW; Bertges DJ; J Vasc Surg; 2016 Mar; 63(3):715-21. PubMed ID: 26603543 [TBL] [Abstract][Full Text] [Related]
33. Pharmacological interventions for hypertension in children. Chaturvedi S; Lipszyc DH; Licht C; Craig JC; Parekh R Evid Based Child Health; 2014 Sep; 9(3):498-580. PubMed ID: 25236305 [TBL] [Abstract][Full Text] [Related]
34. Rationale, design and patient baseline characteristics of OlmeSartan and calcium antagonists randomized (OSCAR) study: a study comparing the incidence of cardiovascular events between high-dose angiotensin II receptor blocker (ARB) monotherapy and combination therapy of ARB with calcium channel blocker in Japanese elderly high-risk hypertensive patients (ClinicalTrials. gov no. NCT00134160). Ogawa H; Kim-Mitsuyama S; Jinnouchi T; Matsui K; Arakawa K Hypertens Res; 2009 Jul; 32(7):575-80. PubMed ID: 19444280 [TBL] [Abstract][Full Text] [Related]
35. The velocity of antihypertensive effect of losartan/hydrochlorothiazide and angiotensin II receptor blocker. Metoki H; Ohkubo T; Kikuya M; Asayama K; Inoue R; Obara T; Hirose T; Sato M; Hashimoto T; Imai Y; J Hypertens; 2012 Jul; 30(7):1478-86. PubMed ID: 22573119 [TBL] [Abstract][Full Text] [Related]
36. Methylene blue: the drug of choice for catecholamine-refractory vasoplegia after cardiopulmonary bypass? Leyh RG; Kofidis T; Strüber M; Fischer S; Knobloch K; Wachsmann B; Hagl C; Simon AR; Haverich A J Thorac Cardiovasc Surg; 2003 Jun; 125(6):1426-31. PubMed ID: 12830064 [TBL] [Abstract][Full Text] [Related]
37. Methylene Blue for Vasoplegia When on Cardiopulmonary Bypass During Double-Lung Transplantation. Carley M; Schaff J; Lai T; Poppers J A A Case Rep; 2015 Oct; 5(8):127-30. PubMed ID: 26466303 [TBL] [Abstract][Full Text] [Related]
38. Choice of treatment based on Turkish hypertension consensus report: Do we follow the recommendations? Yürüyen G; Toprak İD; Toprak Z; Akarsu M; Demir P; Arman Y; Çil EÖ; Özcan M; Irmak S; Altun Ö; Aydın Yoldemir Ş; Eruzun H; Tükek T Turk Kardiyol Dern Ars; 2018 Jan; 46(1):25-31. PubMed ID: 29339688 [TBL] [Abstract][Full Text] [Related]
39. Incidence and predictors of vasoplegia after heart failure surgery. van Vessem ME; Palmen M; Couperus LE; Mertens B; Berendsen RR; Tops LF; Verwey HF; de Jonge E; Klautz RJ; Schalij MJ; Beeres SL Eur J Cardiothorac Surg; 2017 Mar; 51(3):532-538. PubMed ID: 28364440 [TBL] [Abstract][Full Text] [Related]
40. Chronic angiotensin-converting enzyme inhibitor or angiotensin receptor blocker therapy combined with diuretic therapy is associated with increased episodes of hypotension in noncardiac surgery. Kheterpal S; Khodaparast O; Shanks A; O'Reilly M; Tremper KK J Cardiothorac Vasc Anesth; 2008 Apr; 22(2):180-6. PubMed ID: 18375317 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]